Enterobacter Bacteremia: Clinical Features, Risk Factors for Multiresistance and Mortality in a Chinese University Hospital

[1]  C. Wendt,et al.  Risk Factors for Colonization with Third–Generation Cephalosporin–Resistant Enterobacteriaceae , 2005, Infection.

[2]  Donna J. Plonczynski,et al.  Wise use of perioperative antibiotics. , 2005, AORN journal.

[3]  Sung-Han Kim,et al.  Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome , 2004, Antimicrobial Agents and Chemotherapy.

[4]  M. Oh,et al.  Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. Tarrand,et al.  Central Venous Catheter–Related Bacteremia Due to Gram-Negative Bacilli: Significance of Catheter Removal in Preventing Relapse , 2004, Infection Control & Hospital Epidemiology.

[6]  E. Velasco,et al.  Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in adult surgical cancer patients , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[7]  V. Gonçalves,et al.  Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  Y. Mehta,et al.  Central venous catheter-related blood stream infections: incidence, risk factors, outcome, and associated pathogens. , 2004, Journal of cardiothoracic and vascular anesthesia.

[9]  G. Samonis,et al.  Bloodstream Infections in Patients with Solid Tumors: Associated Factors, Microbial Spectrum and Outcome , 2004, Infection.

[10]  J. Woo,et al.  Impact of Previous Use of Antibiotics on Development of Resistance to Extended-Spectrum Cephalosporins in Patients with Enterobacter Bacteremia , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[11]  S. Cosgrove,et al.  Risk Factors for Emergence of Resistance to Broad-Spectrum Cephalosporins among Enterobacterspp , 2001, Antimicrobial Agents and Chemotherapy.

[12]  E. Perencevich.  Excess shock and mortality in Staphylococcus aureus related to methicillin resistance. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  J. Butzler,et al.  Molecular Epidemiological Study of NosocomialEnterobacter aerogenes Isolates in a Belgian Hospital , 1998, Journal of Clinical Microbiology.

[14]  C. Sanders,et al.  Enterobacter spp.: pathogens poised to flourish at the turn of the century , 1997, Clinical microbiology reviews.

[15]  V L Yu,et al.  Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. , 1991, Annals of internal medicine.

[16]  P. Gallagher.  Enterobacter bacteremia in pediatric patients. , 1990, Reviews of infectious diseases.

[17]  E. Bouza,et al.  Enterobacter bacteremia. An analysis of 50 episodes. , 1985, Archives of internal medicine.

[18]  Fu-Der Wang,et al.  Bacteremia in patients with hematological malignancies. , 2005, Chemotherapy.

[19]  Aparna,et al.  Enterobacter bacteremia. , 2003, The Journal of the Association of Physicians of India.